No Data
PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Shareholders Have More To Worry About Than Only Soft Earnings
Pharma Block Sciences (300725.SZ) received a shareholding of 0.0963 million shares from its controlling shareholder, Yang Minmin.
Pharma Block Sciences (300725.SZ) announced that the company received a letter from the controlling shareholder on August 26, 2024, stating that...
A Piece Of The Puzzle Missing From PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) Share Price
Pharma Block Sciences: Summary of Half-Year Report in 2024.
Pharma Block Sciences: Half-year report for the year 2024.
Pharma Block Sciences (300725.SZ): net income of 98.6915 million yuan in the first half of the year, a year-on-year decrease of 13.35%.
Pharma Block Sciences (300725.SZ) released its 2024 semi-annual report with total operating revenue of 74.5 million yuan, down 11.75% year-on-year. Net income attributable to shareholders of the listed company was 98.6915 million yuan, down 13.35% YoY, while net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 67.6139 million yuan, down 37.55% YoY. EPS was 0.50 yuan.
No Data
